𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of pancreatic cancer cell growth

✍ Scribed by T. E. Adrian


Publisher
Springer
Year
2007
Tongue
English
Weight
345 KB
Volume
64
Category
Article
ISSN
1420-682X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Actinomycin D induces apoptosis and inhi
✍ JΓΆrg Kleeff; Marko Kornmann; Harneet Sawhney; Murray Korc πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 366 KB πŸ‘ 2 views

Pancreatic cancer cells are usually resistant to apoptosis induced by cytotoxic drugs, by activation of surface receptors such as Fas and TNF receptor or by serum or growth factor withdrawal. Actinomycin D (actD) is an inhibitor of RNA synthesis and acts as a potent inducer of apoptosis in several c

Basic fibroblast growth factor induces p
✍ M. BensaΓ―d; N. Tahiri-Jouti; C. Cambillau; N. Viguerie; B. Colas; C. Vidal; J. P πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 466 KB πŸ‘ 1 views

AR4-2J, a rat pancreatic acinar-tumor cell line, was used to investigate long-term effects of basic fibroblast growth factor (bFGF) and somatostatin on pancreatic cancer cells. We observed that bFGF stimulated cell proliferation when cells were cultured in serum-free medium. The effect was dose-depe

Zinc depletion efficiently inhibits panc
✍ M. Donadelli; E. Dalla Pozza; C. Costanzo; M.T. Scupoli; A. Scarpa; M. Palmieri πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 333 KB πŸ‘ 1 views

## Abstract We investigated the ability of the zinc chelator __N__,__N__,__Nβ€²__,__Nβ€²__‐tetrakis(2‐pyridylmethyl)ethylenediamine (TPEN) to reduce pancreatic cancer cell viability. TPEN was much more efficient to inhibit pancreatic adenocarcinoma cell growth than a panel of anti‐cancer drugs, includi

Arotinoid mofarotene (RO40-8757) up-regu
✍ Shigeyuki Kawa; Toshio Nikaido; Yuji Aoki; Yali Zhai; Toshiko Kumagaya; Kenichi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 165 KB

Effective chemotherapy for pancreatic cancer is urgently needed. The anti-proliferative activity of a new retinoid, mofarotene (RO40-8757), was compared with that of other retinoids, such as all trans-retinoic acid, 13-cis retinoic acid and 9-cis retinoic acid, on 9 pancreatic cancer cell lines in r